First, there were plain vanilla  mRNA "vaccines." Now, geneticists have created "self-amplifying mRNAs, or replicons, that provide long-lasting humoral and cellular immune responses upon single, low-dose immunization." This is a second-generation development that promises to take center stage in fu…